Shed vs IVIM Health: Coaching and Name-Brand Options vs Ratings
Quick verdict: Shed vs IVIM Health boils down to whether you want integrated coaching plus name-brand GLP-1 options (Shed) or a clinician-guided compounded program with unusually strong third-party ratings and free consults (IVIM Health). This article compares them directly so you can pick the better fit.
Start Shed 2-minute assessment
How they differ at a glance
Shed and IVIM Health both operate as telehealth weight-loss platforms that prescribe GLP-1 medications, but their emphases diverge. Shed highlights name-brand and compounded GLP-1 plus continuous coaching and a fast 2-minute approval assessment. IVIM Health focuses on a structured GLP-1 ID protocol, clinician-guided titration, and a rare 4.9-star rating on Google and Trustpilot, and it offers a free consultation for new patients.
Distinctive difference 1: Medication options and regulatory context
Shed: Offers both FDA-approved name-brand GLP-1 and compounded options, letting patients choose based on budget and preference. The source states that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription.
IVIM Health: Offers compounded semaglutide and tirzepatide only. The source explicitly notes compounded drugs are not FDA-approved and have not undergone FDA review for safety, efficacy, or quality.
Distinctive difference 2: Coaching, protocols, and clinical claims
Shed integrates continuous coaching into treatment rather than simply issuing a prescription. The platform positions coaching as part of the monthly cost and as a differentiator versus script-and-ship competitors.
IVIM Health promotes a proprietary GLP-1 ID protocol and clinician-guided titration that it says can accelerate weight loss outcomes by up to 40% compared to standard GLP-1 protocols. The source frames that 40% figure as IVIM’s claim and not an independent clinical trial result.
Distinctive difference 3: Pricing signals and trial offers
Shed lists starting prices for compounded medications: compounded semaglutide injections starting at $199/month and compounded tirzepatide starting at $299/month, and it advertises 10% off your first month. The source also notes name-brand options carry significantly higher costs than compounded alternatives and that standard pricing is not published for every plan.
IVIM Health shows lower advertised monthly rates for compounded products: semaglutide at $75/mo and tirzepatide at $133/mo in captured landing-page evidence, plus a program fee of $74.99/mo. IVIM also offers a free month membership with code GIFT75 and a no-obligation free consultation valued at $75.
Distinctive difference 4: External validation and patient satisfaction
Shed’s differentiators are product mix and coaching support. The source emphasizes coaching and flexible medication options as the strongest choice for patients wanting more than a prescription.
IVIM Health stands out for a 4.9-star rating on both Google and Trustpilot, described in the source as a rare dual third-party verification and a compelling trust signal for patients who weight-proof their choices via external reviews.
Comparison table
| Criteria | Shed | IVIM Health |
|---|---|---|
| Starting price | Compounded semaglutide starting at $199/month; tirzepatide starting at $299/month; 10% off first month | Captured rates show semaglutide $75/mo and tirzepatide $133/mo plus $74.99/mo program fee; free month with code GIFT75 |
| Medication options | Name-brand and compounded GLP-1 options on one platform | Compounded GLP-1 only |
| Coaching and protocol | Continuous coaching integrated into treatment | GLP-1 ID clinician-guided protocol with structured titration |
| Consultation speed or offer | 2-minute approval assessment followed by clinician review | No-obligation free consultation valued at $75; first month free with code |
| Third-party ratings | Not supplied in source | 4.9-star rating on Google and Trustpilot per source |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and have not undergone FDA review for safety, efficacy, or quality |
How the intake and costs compare in practice
Shed uses a 2-minute online assessment to check eligibility quickly and then a licensed clinician reviews your case before prescribing name-brand or compounded options. Pricing for name-brand options is higher and Shed does not publish standard pricing for all plans, offering personalized quotes after intake.
IVIM Health provides a free consultation for new patients and promotional codes that reduce the first-month barrier. The source lists an ongoing $174/month rate in FAQ content and notes the first month can be $99 in some messaging; the captured landing-page evidence includes lower monthly figures and a program fee. Note that the source frames these figures as IVIM’s published pricing structure.
Explore Shed options and coaching
Safety and evidence notes
Both sources emphasize that compounded medications are not FDA-approved and are made by licensed compounding pharmacies based on a provider’s prescription. IVIM cites internal and retrospective observational studies in Obesity Pillars for outcomes related to its protocol, and frames those as not randomized head-to-head trials. Shed cites clinical trial results for branded Wegovy only as context and notes results may vary.
See Shed pricing and start assessment
Bottom line and who should choose which
When deciding between Shed vs IVIM Health, pick based on whether you value integrated coaching and access to name-brand GLP-1, or whether you prioritize third-party ratings and a structured proprietary protocol with promotional free consults.
Choose Shed if you want integrated continuous coaching, the option to choose FDA-approved name-brand medications alongside compounded alternatives, and a fast 2-minute assessment. Choose IVIM Health if you want a clinician-guided GLP-1 ID protocol, unusually strong 4.9-star third-party ratings, and a free no-obligation consultation plus promotional first-month offers.